Vimarsana
Biggest News Aggregation in the World

Huating Li News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Huating Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Huating Li Today - Breaking & Trending Today

Resistant Starch May Help Lower Risk of Fatty Liver Disease, Finds Study - Vimarsana News

Resistant Starch May Help Lower Risk of Fatty Liver Disease, Finds Study

Resistant starch is a non-digestible fibre that ferments in the large intestine. Consumption of such starch has been previously shown to have a positive effect on metabolism, in animal studies.

Resistant Starch Reduces Liver Triglycerides in Fatty Liver Disease - Vimarsana News

Resistant Starch Reduces Liver Triglycerides in Fatty Liver Disease

Unlike strenuous exercise or weight loss treatments, adding resistant starch to a balanced diet is more feasible for those with alcoholic fatty liver disease.

New approach in the treatment of non-alcoholi - Vimarsana News

New approach in the treatment of non-alcoholi

The prebiotic resistant starch could play an important role in the treatment of non-alcoholic fatty liver disease (NAFLD) in the future. Initial indications suggest that a specially adapted diet with resistant starch not only positively influences the intestinal microbiome but also leads to an alleviation of the disease. This is what an international research team from the “Balance of the Microverse” Cluster of Excellence at the University of Jena, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (SSPH-SJTUSM) and the Leibniz Institute fo...

Research shows how resistant starch could slow down progression of non-alcoholic fatty liver disease - Vimarsana News

Research shows how resistant starch could slow down progression of non-alcoholic fatty liver disease

The prebiotic resistant starch could play an important role in the treatment of non-alcoholic fatty liver disease (NAFLD) in the future.

Microbiota-Targeted Intervention Decreases IHTC in Patients With NAFLD - Vimarsana News

Microbiota-Targeted Intervention Decreases IHTC in Patients With NAFLD

The clinical trial compared outcomes in patients with NAFLD on a resistant starch diet to a control group over a 4-month period, with results suggesting microbiota dietary supplements may improve liver conditions.